Marina brings over 16 years of life sciences experience spanning strategy and pharma. Her key focus areas include commercial strategy and excellence, omnichannel customer engagement, commercial model design, and go-to-market and launch strategy, with therapeutic depth in CVRM (with a focus in obesity), oncology, and neuroscience. Prior to joining Blue Matter, she spent 14 years in consulting and leadership roles at IQVIA (formerly IMS Consulting Group) and began her career on the industry side at Novartis. Marina holds an MRes in Structural Biology and a B.Sc. in Biochemistry, both from Imperial College London, where she also researched drug targets for Type 2 Diabetes.